USANA Health Sciences (NYSE: USNA) reported Q4 EPS of $1.65, $0.28 worse than the analyst estimate of $1.93. Revenue for the quarter came in at $227.9 million versus the consensus estimate of $219.1 million.

USANA Health Sciences sees FY2015 EPS of $6.40-$6.70, versus the consensus of $6.73. USANA Health Sciences sees FY2015 revenue of $850-870 million, versus the consensus of $823.55 million.

For earnings history and earnings-related data on USANA Health Sciences (USNA) click here.